StonvexLoading…
StonvexStonvexStonvexCore line items from OMCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $316.46M | $309.88M | $1.18B | $870.86M | $560.23M |
Operating Income | Not available | $16.85M | $5.16M | $4.75M | $-3.50M |
Net Income | Not available | $11.36M | $2.05M | $4.08M | $5.64M |
EPS (Diluted) | $0.48 | $0.25 | $0.04 | $0.09 | $-0.03 |
Total Assets | Not available | $2.00B | $1.97B | $1.95B | $2.15B |
Total Liabilities | Not available | $747.48M | $742.91M | $727.70M | $881.88M |
Cash & Equivalents | Not available | $239.22M | $196.52M | $180.05M | $399.00M |
Free Cash Flow OCF − CapEx | Not available | $42.06M | $86.89M | $64.24M | $45.73M |
Shares Outstanding | Not available | 45.48M | 45.03M | 44.88M | 46.42M |